194 related articles for article (PubMed ID: 1693669)
1. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients.
Warren KG; Catz I
J Neurol Sci; 1990 Apr; 96(1):19-27. PubMed ID: 1693669
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission.
Warren KG; Catz I
J Neurol Sci; 1988 Dec; 88(1-3):185-94. PubMed ID: 2465390
[TBL] [Abstract][Full Text] [Related]
3. Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.
Warren KG; Catz I
J Neurol Sci; 1991 May; 103(1):90-6. PubMed ID: 1713953
[TBL] [Abstract][Full Text] [Related]
4. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.
Warren KG; Catz I
J Neurol Sci; 1994 Jan; 121(1):66-73. PubMed ID: 7510787
[TBL] [Abstract][Full Text] [Related]
5. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
6. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis.
Warren KG; Catz I
J Neuroimmunol; 1993 Mar; 43(1-2):87-96. PubMed ID: 7681451
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Detection during first exacerbations and kinetics of acute relapses and subsequent convalescent phases.
Warren KG; Catz I
J Neurol Sci; 1989 Jun; 91(1-2):143-51. PubMed ID: 2473170
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue.
Warren KG; Catz I
J Neurol Sci; 1993 Apr; 115(2):169-76. PubMed ID: 7683331
[TBL] [Abstract][Full Text] [Related]
9. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.
O'Connor KC; Chitnis T; Griffin DE; Piyasirisilp S; Bar-Or A; Khoury S; Wucherpfennig KW; Hafler DA
J Neuroimmunol; 2003 Mar; 136(1-2):140-8. PubMed ID: 12620653
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis.
Catz I; Warren KG
Can J Neurol Sci; 1986 Feb; 13(1):21-4. PubMed ID: 2420428
[TBL] [Abstract][Full Text] [Related]
11. Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid.
Link H; Baig S; Olsson O; Jiang YP; Höjeberg B; Olsson T
J Neuroimmunol; 1990 Aug; 28(3):237-48. PubMed ID: 1695639
[TBL] [Abstract][Full Text] [Related]
12. Purification of primary antibodies of the myelin basic protein antibody cascade from multiple sclerosis patients. Immunoreactivity studies with homologous and heterologous antigens.
Warren KG; Catz I
Clin Invest Med; 1992 Feb; 15(1):18-29. PubMed ID: 1373999
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients.
Maimone D; Annunziata P; Cioni C; Leonardi A; Guazzi GC
Acta Neurol Scand; 1994 Oct; 90(4):285-92. PubMed ID: 7530889
[TBL] [Abstract][Full Text] [Related]
14. CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis.
Panitch HS; Hooper CJ; Johnson KP
Arch Neurol; 1980 Apr; 37(4):206-9. PubMed ID: 6153890
[TBL] [Abstract][Full Text] [Related]
15. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis.
García-Merino A; Persson MA; Ernerudh J; Díaz-Gil JJ; Olsson T
J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1066-70. PubMed ID: 2428940
[TBL] [Abstract][Full Text] [Related]
16. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
Wajgt A; Górny M
Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
[TBL] [Abstract][Full Text] [Related]
17. Optic neuritis anti-myelin basic protein synthetic peptide specificity.
Warren KG; Catz I; Shutt K
J Neurol Sci; 1992 May; 109(1):88-95. PubMed ID: 1381412
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
19. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
Warren KG; Catz I; Johnson E; Mielke B
Ann Neurol; 1994 Mar; 35(3):280-9. PubMed ID: 7510098
[TBL] [Abstract][Full Text] [Related]
20. Myelin basic protein antibodies in the serum and CSF of multiple sclerosis and subacute sclerosing panencephalitis patients.
Ruutiainen J; Arnadottir T; Molnár G; Salmi A; Frey H
Acta Neurol Scand; 1981 Sep; 64(3):196-206. PubMed ID: 6171986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
